Manchester Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Manchester Financial’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-200	Closed	-$27K	–	662
2021 Q1	$27K	Hold	200	–	–	0.01%	272
2020 Q4	$28K	Hold	200	–	–	0.02%	232
2020 Q3	$22K	Sell	200 -200	-50%	-$22.4K	0.02%	229
2020 Q2	$45K	Buy	400 +200	+100%	+$19.7K	0.04%	134
2020 Q1	$15K	Hold	200	–	–	0.01%	255
2019 Q4	$19K	Buy	+200	New	+$17.3K	0.01%	280
2019 Q3	–	Sell	-200	Closed	-$18K	–	445
2019 Q2	$18K	Buy	+200	New	+$17.1K	0.01%	258

Other funds holding XBI

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Manchester Financial's XBI Position: Q2 2021 in Review

Manchester Financial sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2021, closing a stake of 200 shares — an estimated $27K sold.

Manchester Financial first reported a position in XBI in Q2 2019 and held it in 7 quarters. The position peaked at $45K in Q2 2020. 663 funds tracked by Wall St. Rank hold XBI as of Q2 2021.

Manchester Financial reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2021 after selling out during the quarter.
Manchester Financial sold 200 State Street SPDR S&P Biotech ETF shares in Q2 2021, an estimated $27K.
Manchester Financial first reported a position in State Street SPDR S&P Biotech ETF in Q2 2019 and held it in 7 quarters.
Manchester Financial's State Street SPDR S&P Biotech ETF position peaked at $45K in Q2 2020.
663 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2021.

Based on Manchester Financial's 13F filing for Q2 2021, filed 21 Jul 2021.